Search

everythinglearnresearchcommunity

for

Search:↓

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

WNT10B is important for body functions and linked to diseases like osteoporosis, obesity, and cancer.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Tph cells are linked to the severity of systemic lupus erythematosus.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.